National practice patterns and time trends in primary and neoadjuvant androgen ablation for prostate cancer: Data from CaPSURE

被引：0
|
作者：
Cooperberg, MR
Grossfeld, GD
Lubeck, DP
Carroll, PR
机构：
来源：
JOURNAL OF UROLOGY | 2003年 / 169卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
50
引用
收藏
页码：13 / 13
页数：1
相关论文
共 50 条
  • [31] Competing causes of death in men with prostate cancer: Data from capsure
    Meng, MV
    Sadetsky, N
    Latini, DM
    Duchane, J
    Carroll, PR
    JOURNAL OF UROLOGY, 2006, 175 (04): : 44 - 44
  • [32] Is obesity associated with more aggressive prostate cancer? (Data from CaPSURE)
    Kane, CJ
    Bassett, WW
    Sadetsky, N
    Silva, SJ
    Pasta, DJ
    Cooperberg, MR
    Chan, JM
    Wallace, KL
    Carroll, PR
    JOURNAL OF UROLOGY, 2004, 171 (04): : 124 - 124
  • [33] Health related quality of life patterns in patients treated with interstitial prostate brachytherapy for localized prostate cancer - Data from CaPSURE
    Downs, TM
    Sadetsky, N
    Pasta, DJ
    Grossfeld, GD
    Kane, CJ
    Mehta, SS
    Carroll, PR
    Lubeck, DP
    JOURNAL OF UROLOGY, 2003, 170 (05): : 1822 - 1827
  • [34] Longitudinal assessment of changes in sexual function and bother in patients treated with external beam radiotherapy or brachytherapy, with and without neoadjuvant androgen ablation: Data from capsure
    Speight, JL
    Elkin, EP
    Pasta, DJ
    Silva, S
    Lubeck, DP
    Carroll, PR
    Litwin, MS
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (04): : 1066 - 1075
  • [35] Molecular alterations in primary prostate cancer after androgen ablation therapy
    Best, CJM
    Gillespie, JW
    Yi, YJ
    Chandramouli, GVR
    Perlmutter, MA
    Gathright, Y
    Erickson, HS
    Georgevich, L
    Tangrea, MA
    Duray, PH
    González, S
    Velasco, A
    Linehan, WM
    Matusik, RJ
    Price, DK
    Figg, WD
    Emmert-Buck, MR
    Chuaqui, RF
    CLINICAL CANCER RESEARCH, 2005, 11 (19) : 6823 - 6834
  • [36] Neoadjuvant androgen ablation prior to radiotherapy for prostate cancer: Reducing the potential morbidity of therapy
    Zelefsky, MJ
    Harrison, A
    UROLOGY, 1997, 49 (3A) : 38 - 45
  • [37] Time trends and characteristics of men choosing watchful waiting for initial treatment of localized prostate cancer: Results from CaPSURE
    Harlan, SR
    Cooperberg, MR
    Elkin, EP
    Lubeck, DP
    Meng, MV
    Mehta, SS
    Carroll, PR
    JOURNAL OF UROLOGY, 2003, 170 (05): : 1804 - 1807
  • [38] TRENDS IN UTILIZATION OF PRIMARY ANDROGEN DEPRIVATION THERAPY FOR LOCALIZED PROSTATE CANCER
    Haseebuddin, Mohammed
    Handorf, Elizabeth
    Wong, Yu-Ning
    Kim, Simon
    Wainganker, Nikhil
    Kutikov, Alexander
    Bekelman, Justin
    Uzzo, Robert
    Smaldone, Marc
    JOURNAL OF UROLOGY, 2015, 193 (04): : E257 - E257
  • [39] Obesity and prostate cancer clinical risk factors at presentation: Data from CaPSURE
    Kane, CJ
    Bassett, WW
    Sadetsky, N
    Silva, S
    Wallace, K
    Pasta, DJ
    Cooperberg, MR
    Chan, JM
    Carroll, PR
    JOURNAL OF UROLOGY, 2005, 173 (03): : 732 - 736
  • [40] Quality of life after second treatment for prostate cancer:: Data from CaPSURE™
    Lubeck, DP
    Sadetsky, N
    Pasta, DJ
    Mehta, SS
    Carroll, PR
    JOURNAL OF UROLOGY, 2003, 169 (04): : 34 - 34
12345